Fundraising FoxCare Capital
Venture capitalPrinceton · Seed–Growth
Find your way into Care Capital
Sign up to see every warm intro you have to Care Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Care Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 2 of 2 portfolio companiesBiotech ×2Healthtech ×2Digital Health ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro path
Minerva Neurosciences is a clinical-stage biopharmaceutical company developing product candidates for central nervous system disorders.
BiotechHealthtechWaltham, US
Joseph Reilly(Executive Officer)Geoff Race(Executive Officer)inFred Ahlholm(Executive Officer)inRemy Luthringer(Executive Officer, Director)Mark Levine(Executive Officer)
BoardMichele Ollier(Director)in
Co-investorsVivo CapitalIndex VenturesLifeSci Venture PartnersMedicxi
Vanda is a biopharmaceutical company that develops new medicines, using genetics and genomics to guide drug discovery, clinical trials, and commercial positioning of its compounds.
BiotechDigital HealthHealthtechWashington, US
Mihalis Polymeropoulos(Founder & CEO)Mihael Polymeropoulos(President, Chief Executive Officer and Chairman of the Board)
Co-investorsRho Ventures
Exits · 2
2 IPOs · showing 1Minerva NeurosciencesNASDAQ: NERV
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Minerva Neurosciences | 16.7% | $6.00 | Jul 2014 | $18.9M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- What stage does Care Capital invest at?
- Care Capital invests at the Seed, Series A, Growth stages.
- What sectors does Care Capital focus on?
- Care Capital focuses on Biotech.
- Where is Care Capital located?
- Care Capital is headquartered in Princeton, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.